menu
    • menu

    Company profile for Atom Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Atomera Incorporated is a materials engineering company based in Los Gatos, California, specializing in the development and licensing of advanced semiconductor technologies. Their flagship innovation, Mears Silicon Technology™ (MST®), is a patented, quantum-engineered material designed to enhance transistor performance, leading to improved efficiency in electronic devices. MST® achieves this by forming a superlattice struc...
    Atomera Incorporated is a materials engineering company based in Los Gatos, California, specializing in the development and licensing of advanced semiconductor technologies. Their flagship innovation, Mears Silicon Technology™ (MST®), is a patented, quantum-engineered material designed to enhance transistor performance, leading to improved efficiency in electronic devices. MST® achieves this by forming a superlattice structure within silicon, which optimizes electron mobility and reduces variability, thereby enabling faster and more power-efficient semiconductors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Atom TherapeuticsChina Flag
    Country
    Country
    China
    Address
    Address
    Suzhou, Jiangsu
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.atomthera.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/atom-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Atom Therapeutics Unveils Gout Therapy Partnership Prospects
    Atom Therapeutics Unveils Gout Therapy Partnership Prospects

    28 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251028054949/en/Atom-Therapeutics-Announces-Partnering-Opportunities-For-New-Gout-Therapies-at-BIO-Europe-2025-in-Vienna

    BUSINESSWIRE
    28 Oct 2025
    Share Share
    Atom to Present Positive Gout Drug Data at ACR Convergence 2025
    Atom to Present Positive Gout Drug Data at ACR Convergence 2025

    21 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251021318243/en/Atom-Therapeutics-to-Present-Positive-Data-from-Clinical-Trials-of-Its-Lead-Novel-Oral-Drugs-for-Chronic-Gout-and-Acute-Gout-Flares-at-ACR-Convergence-2025

    BUSINESSWIRE
    21 Oct 2025
    Share Share
    Atom Therapeutics Begins Ph 2 of ABP-745 for Acute Gout Flares
    Atom Therapeutics Begins Ph 2 of ABP-745 for Acute Gout Flares

    15 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250915080338/en/Atom-Therapeutics-Enrolls-First-Patient-in-Multicenter-Global-Phase-2-Trial-of-ABP-745-for-Acute-Gout-Flares

    BUSINESSWIRE
    15 Sep 2025
    Share Share
    Atom Therapeutic Join Gout Education Society on Gout Awareness Day
    Atom Therapeutic Join Gout Education Society on Gout Awareness Day

    23 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250522595360/en/Atom-Therapeutics-Joins-Gout-Education-Society-on-Gout-Awareness-Day-May-22-to-Help-Educate-the-Public-on-Risk-Factors-and-Treatment-Options-for-This-Growing-Disease

    BUSINESSWIRE
    23 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search